Key result
MitraClip evaluation protocol details percutaneous edge-to-edge repair methodology for severe systemic TR in ccTGA.
Why the study?
Patients with ccTGA and severe systemic AV-valve regurgitation have high predicted surgical risk, necessitating evaluation of percutaneous repair feasibility and safety.
Does percutaneous edge-to-edge repair using the MitraClip system provide a feasible and safe treatment for severe tricuspid regurgitation in high-surgical-risk patients with congenitally corrected transposition of the great arteries?
Observational
Does percutaneous edge-to-edge repair using the MitraClip system provide a feasible and safe treatment for severe tricuspid regurgitation in high-surgical-risk patients with congenitally corrected transposition of the great arteries?
Percutaneous edge-to-edge repair using the MitraClip system is being evaluated for feasibility and safety in high-surgical-risk patients with congenitally corrected transposition of the great arteries and severe systemic tricuspid regurgitation.
No takes yet. Share an insight, caveat, or question.
No clinical outcomes reported for MitraClip in ccTGA; leaves open feasibility and efficacy of percutaneous repair in this anatomy.
Rumpf et al. (2018) conducted an observational in Severe tricuspid regurgitation in congenitally corrected transposition of the great arteries (ccTGA). Percutaneous edge-to-edge repair using the MitraClip system was evaluated on Feasibility and safety (TR grade). The abstract describes the methodology for evaluating percutaneous edge-to-edge repair using MitraClip for severe systemic tricuspid regurgitation in ccTGA, but reports no clinical results.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: